Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Humacyte Inc.

    NASDAQ: HUMAW · Real-Time Price · USD
    0.51
    -0.06 (-10.53%)
    At close: Jun 18, 2025, 3:59 PM
    0.51
    0.00%
    After-hours: Jun 18, 2025, 04:00 PM EDT

    Humacyte Statistics

    Share Statistics

    Humacyte has 648.56M shares outstanding. The number of shares has increased by null% in one year.

    Shares Outstanding

    n/a
    		 648.56M

    Shares Change (YoY)

    n/a
    		 n/a

    Shares Change (QoQ)

    n/a
    		 n/a

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 15

    FTD / Avg. Volume

    n/a
    		 0.05%

    Short Selling Information

    The latest short interest is 7.42K, so 0% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 7.42K

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -4.02 and the forward PE ratio is -1.96. Humacyte's PEG ratio is -0.23.

    PE Ratio

    n/a
    		 -4.02

    Forward PE

    n/a
    		 -1.96

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.6

    PB Ratio

    n/a
    		 -11.36

    P/FCF Ratio

    n/a
    		 -6

    PEG Ratio

    n/a
    		 -0.23
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Humacyte.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.4, with a Debt / Equity ratio of -0.31.

    Current Ratio

    n/a
    		 2.4

    Quick Ratio

    n/a
    		 2.4

    Debt / Equity

    n/a
    		 -0.31

    Debt / EBITDA

    n/a
    		 -0.13

    Debt / FCF

    n/a
    		 -0.17

    Interest Coverage

    n/a
    		 -12.33

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-682,114.68

    Employee Count

    n/a
    		 218

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -71.19% in the last 52 weeks. The beta is 2, so Humacyte's price volatility has been higher than the market average.

    Beta

    n/a
    		 2

    52-Week Price Change

    n/a
    		 -71.19%

    50-Day Moving Average

    n/a
    		 0.45

    200-Day Moving Average

    n/a
    		 1.24

    Relative Strength Index (RSI)

    n/a
    		 47.25

    Average Volume (20 Days)

    n/a
    		 28,655

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -114.4M

    Net Income

    n/a
    		 -148.7M

    EBITDA

    n/a
    		 -132.23M

    EBIT

    n/a
    		 -139.42M

    Earnings Per Share (EPS)

    n/a
    		 -1.26
    Full Income Statement

    Balance Sheet

    The company has 44.94M in cash and 16.54M in debt, giving a net cash position of 28.4M.

    Cash & Cash Equivalents

    n/a
    		 44.94M

    Total Debt

    n/a
    		 16.54M

    Net Cash

    n/a
    		 28.4M

    Retained Earnings

    n/a
    		 -686.01M

    Total Assets

    n/a
    		 162.55M

    Working Capital

    n/a
    		 53.68M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -98.12M and capital expenditures -1.57M, giving a free cash flow of -99.69M.

    Operating Cash Flow

    n/a
    		 -98.12M

    Capital Expenditures

    n/a
    		 -1.57M

    Free Cash Flow

    n/a
    		 -99.69M

    FCF Per Share

    n/a
    		 -0.84
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    HUMAW does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for HUMAW.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -5.99

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist